A halt to neuroblastoma screening in Japan - PubMed (original) (raw)
Comment
A halt to neuroblastoma screening in Japan
Yoshitaka Tsubono et al. N Engl J Med. 2004.
No abstract available
Comment on
- Screening of infants and mortality due to neuroblastoma.
Woods WG, Gao RN, Shuster JJ, Robison LL, Bernstein M, Weitzman S, Bunin G, Levy I, Brossard J, Dougherty G, Tuchman M, Lemieux B. Woods WG, et al. N Engl J Med. 2002 Apr 4;346(14):1041-6. doi: 10.1056/NEJMoa012387. N Engl J Med. 2002. PMID: 11932470 - Neuroblastoma screening at one year of age.
Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, Klein G, Sander J, Schwarz K, Treuner J, Zorn U, Michaelis J. Schilling FH, et al. N Engl J Med. 2002 Apr 4;346(14):1047-53. doi: 10.1056/NEJMoa012277. N Engl J Med. 2002. PMID: 11932471
Similar articles
- Results of mass screening for neuroblastoma in Sapporo, Japan.
Takeda T, Nishi M, Shimada M, Nakadate H, Hatae Y, Naito H, Hanai J, Kawai T, Takasugi N. Takeda T, et al. Prog Clin Biol Res. 1991;366:595-601. Prog Clin Biol Res. 1991. PMID: 2068178 No abstract available. - Past and future of neuroblastoma screening in Japan.
Sawada T. Sawada T. Am J Pediatr Hematol Oncol. 1992 Nov;14(4):320-6. Am J Pediatr Hematol Oncol. 1992. PMID: 1456397 - Neuroblastoma screening in early life.
Collins MH. Collins MH. N Engl J Med. 2002 Sep 12;347(11):852-4; author reply 852-4. N Engl J Med. 2002. PMID: 12227370 No abstract available. - Contribution of HPLC mass screening for neuroblastoma to a decrease in mortality.
Nishi M, Takeda T, Hatae Y, Hanai J, Fujita K, Ichimiya H, Tanaka T. Nishi M, et al. J Exp Clin Cancer Res. 2002 Mar;21(1):73-8. J Exp Clin Cancer Res. 2002. PMID: 12071533 - Newborn screening for neuroblastoma.
Parker L. Parker L. Curr Opin Pediatr. 1997 Feb;9(1):70-3. doi: 10.1097/00008480-199702000-00014. Curr Opin Pediatr. 1997. PMID: 9088758 Review.
Cited by
- Extracellular vesicles in neuroblastoma: role in progression, resistance to therapy and diagnostics.
Dhamdhere MR, Spiegelman VS. Dhamdhere MR, et al. Front Immunol. 2024 Apr 9;15:1385875. doi: 10.3389/fimmu.2024.1385875. eCollection 2024. Front Immunol. 2024. PMID: 38660306 Free PMC article. Review. - Aligning Patient Safety and Stewardship: A Harm Reduction Strategy for Children.
Schefft M, Noda A, Godbout E. Schefft M, et al. Curr Treat Options Pediatr. 2021;7(3):138-151. doi: 10.1007/s40746-021-00227-6. Epub 2021 Jul 12. Curr Treat Options Pediatr. 2021. PMID: 38624879 Free PMC article. Review. - Functionalized GD2 Electrochemical Immunosensor to Diagnose Minimum Residual Disease of Bone Marrow in Neuroblastoma Effectively.
Chen C, Hu C, He B, Bai Y, He F, Li S, Tan CS. Chen C, et al. Biosensors (Basel). 2023 Oct 10;13(10):920. doi: 10.3390/bios13100920. Biosensors (Basel). 2023. PMID: 37887113 Free PMC article. - A rare case of pediatric primary central nervous system differentiating neuroblastoma: an unusual and rare intracranial primitive neuroectodermal tumor (a case report).
Borni M, Znazen M, Mdhaffar N, Boudawara MZ. Borni M, et al. Pan Afr Med J. 2021 Sep 13;40:33. doi: 10.11604/pamj.2021.40.33.30587. eCollection 2021. Pan Afr Med J. 2021. PMID: 34795814 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical